Praxis Precision Medicines (PRAX) Stock Statistics & Valuation Metrics

Praxis Precision Medicines has a market cap or net worth of $1.10B. The enterprise value is $892.45M.

Praxis Precision Medicines has 20,368,982 shares outstanding. The number of shares has decreased by -2.65% in one year.

Praxis Precision Medicines’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -44.80%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.

In the last 12 months, operating cash flow was -163.91M and capital expenditures 64.00K, giving a free cash flow of -163.85M billion.

Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―

Praxis Precision Medicines upcoming earnings date is Aug 19, 2025, Before Open (Confirmed).

Praxis Precision Medicines as a current ratio of 10.77, with Debt / Equity ratio of 0.24%

In the past 12 months, Praxis Precision Medicines has paid 0.00 in taxes.

Praxis Precision Medicines EV to EBITDA ratio is -5.83, with an EV/FCF ratio of -8.84.

Praxis Precision Medicines has $327.99M in cash and marketable securities with $1.07M in debt, giving a net cash position of -$326.93M billion.

Gross margin is 98.10%, with operating margin of -2340.29%, and net profit margin of -2137.48%.

The average price target for Praxis Precision Medicines is $113.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy